1 |
ZHENG R S, ZHANG S, ZENG H, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9.
|
2 |
CABANILLAS M E, MCFADDEN D G, DURANTE C. Thyroid cancer[J]. Lancet, 2016, 388(10061): 2783-2795.
|
3 |
COOPER D S. Radioiodine for low-risk thyroid cancer- the swinging pendulum[J].N Engl J Med,2022,386(10): 990-991.
|
4 |
WEI W J, HARDIN H, LUO Q Y. Targeting autophagy in thyroid cancers[J]. Endocr Relat Cancer, 2019, 26(4): R181-R194.
|
5 |
FOGLI S, GIANFILIPPO G, CUCCHIARA F, et al. Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer[J]. Crit Rev Oncol Hematol, 2021, 163: 103366.
|
6 |
DIXON S J, LEMBERG K M, LAMPRECHT M R, et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.
|
7 |
RYSMAN E, BRUSSELMANS K, SCHEYS K, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation[J].Cancer Res,2010,70(20):8117-8126.
|
8 |
WANG H H, MA J N, ZHAN X R. Circular RNA Circ_0067934 attenuates ferroptosis of thyroid cancer cells by miR-545-3p/SLC7A11 signaling[J]. Front Endocrinol (Lausanne), 2021, 12: 670031.
|
9 |
WANG L D, ZHANG Y, YANG J P, et al. The knockdown of ETV4 inhibits the papillary thyroid cancer development by promoting ferroptosis upon SLC7A11 downregulation[J].DNA Cell Biol,2021,40(9):1211-1221.
|
10 |
WANG X W, XU S C, ZHANG L, et al. Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation[J]. Biochem Biophys Res Commun, 2021, 551: 46-53.
|
11 |
WANG Y, YANG J, CHEN S, et al. Identification and validation of a prognostic signature for thyroid cancer based on ferroptosis-related genes[J]. Genes (Basel), 2022, 13(6): 997.
|
12 |
LOVE M I, HUBER W, ANDERS S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol,2014,15(12): 550.
|
13 |
LIU J F, LICHTENBERG T, HOADLEY K A,et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics[J]. Cell, 2018, 173(2): 400-416.
|
14 |
STELZER G, ROSEN N, PLASCHKES I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses[J]. Curr Protoc Bioinformatics, 2016.DOI:10.1002/cpbi.5 .
doi: 10.1002/cpbi.5
|
15 |
ZHOU N, BAO J K. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations[J]. Database (Oxford), 2020, 2020: baaa021.
|
16 |
COLWILL K, GROUP R P B W, GRÄSLUND S. A roadmap to generate renewable protein binders to the human proteome[J]. Nat Methods,2011,8(7): 551-558.
|
17 |
LIU B, FU T T, HE P, et al. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer[J]. Biosci Rep, 2021, 41(7): BSR20204301.
|
18 |
RITCHIE M E, PHIPSON B, WU D, et al. Limma Powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): e47.
|
19 |
SZKLARCZYK D, GABLE A L, NASTOU K C,et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets[J]. Nucleic Acids Res, 2021, 49(D1): D605-D612.
|
20 |
CHIN C H, CHEN S H, WU H H, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome[J]. BMC Syst Biol, 2014,8(): S11.
|
21 |
YU G C, WANG L G, HAN Y Y,et al. clusterProfiler: an R package for comparing biological themes among gene clusters[J]. OMICS, 2012, 16(5): 284-287.
|
22 |
JOHAR J, BRITTON H, WISEMAN S M. Older patients with differentiated thyroid cancer exhibit more aggressive pathological characteristics than younger patients[J]. Can J Surg, 2020, 63(1): E69-E70.
|
23 |
WANG T S, SOSA J A.Thyroid surgery for differentiated thyroid cancer-recent advances and future directions[J].Nat Rev Endocrinol,2018,14(11): 670-683.
|
24 |
SIFONTES-DUBÓN M, GARCÍA-LÓPEZ J M, GONZÁLEZ-ORTEGA N, et al. Evaluation of a clinical pathway for thyroid nodular disease: timings and delays in the diagnosis and treatment of thyroid cancer[J]. J Clin Med, 2021, 10(23): 5681.
|
25 |
PITOIA F, JERKOVICH F. Selective use of sorafenib in the treatment of thyroid cancer[J]. Drug Des Devel Ther, 2016, 10: 1119-1131.
|
26 |
DE FALCO V, TAMBURRINO A, VENTRE S,et al. CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells[J]. Cancer Res, 2012, 72(6): 1449-1458.
|
27 |
GOMEZ K E, WU F, KEYSAR S B, et al. Cancer cell CD44 mediates macrophage/monocyte-driven regulation of head and neck cancer stem cells[J]. Cancer Res, 2020, 80(19): 4185-4198.
|
28 |
LI H N, ZHANG H M, LI X R, et al. miR-205-5p/GGCT attenuates growth and metastasis of papillary thyroid cancer by regulating CD44[J]. Endocrinology, 2022, 163(4): bqac022.
|
29 |
LI Q C, LIU W, WANG Z L, et al. Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation[J]. Int J Oncol, 2021, 59(6): 104.
|
30 |
JIANG C, HE J L, XU S W, et al. NR4A1 promotes LEF1 expression in the pathogenesis of papillary thyroid cancer[J]. Cell Death Discov, 2022, 8(1): 46.
|
31 |
KO J, JANG S, KWON W, et al. Protective effect of GIP against monosodium glutamate-induced ferroptosis in mouse hippocampal HT-22 cells through the MAPK signaling pathway[J].Antioxidants (Basel), 2022, 11(2):189.
|
32 |
ZHOU B R, LIU J, KANG R, et al. Ferroptosis is a type of autophagy-dependent cell death[J]. Semin Cancer Biol, 2020, 66: 89-100.
|
33 |
CHANG W T, BOW Y D, FU P J, et al. A marine terpenoid, heteronemin, induces both the apoptosis and ferroptosis of hepatocellular carcinoma cells and involves the ROS and MAPK pathways[J]. Oxid Med Cell Longev, 2021, 2021: 7689045.
|